Area under the serum creatinine time-curve is a strong predictor of chronic renal allograft rejection

Transplantation

Volumn 69, Issue 5, 2000, Pages 964-968

  Setterberg, Lina ^a   Elinder, Carl G ^a   Michael Fored, C ^a   Tyden, Gunnar ^a   Reinholt, Finn P ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GRAFT REJECTION; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034653645     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200003150-00050     Document Type: Article

References (30)

1. Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: a reexamination. Am J Kidney Dis 1989; 13: 200.
2. Khan IH, Garrat Am, Kumar A, et al. Patients' perception of health on renal replacement therapy: evaluation using a new instrument. Nephrol Dial Transplant 1995; 10: 684.
3. Sayegh MH, Carpenter CB. Chronic renal allograft rejection. In: Rose BD, ed. Up to date in medicine. Boston: Up to Date in Medicine, Inc., Vol.5 No.2, 1998.
4. Vanrenterghem Y, Peeters J. Impact of cyclosporine on chronic rejection and graft vasculopathy. Transplant Proc 1994; 26: 2560.
5. Paul LC. Chronic rejection of organ allografts: magnitude of the problem. Transplant Proc 1993; 25: 2024.
6. Hostetter TH. Chronic transplant rejection. Kidney Int 1994; 46: 266.
7. Yilmaz S, Yilmaz A, Häyry P. Chronic renal allograft rejection can be predicted by area under the serum creatinine versus time curve (AUC Cr). Kidney Int 1995; 48: 251.
8. Paul LC, Häyry P, Foegh M et al. Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: joint proposal from the Fourth Alexis Carrel conference on chronic rejection and accelerated arteriosclerosis in transplanted organs. Transplant Proc 1993; 25: 2022.
9. Solez K, Axelsen R A, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
10. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47: 1491.
11. Brickman AL, Finns AI. Kidney allograft survival: relationship to dialysis compliance and other behaviours. Dial Transplant 1996; 25: 88.
12. Lindholm A, Ohlman S, Albrechtsen D, Tufveson G, Persson H, Persson NH. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56: 307.
13. Cecka JM. Early rejection: determining the fate of renal transplants. Transplant Proc 1991; 23: 1263.
14. Foster MC, Rowe PA, Dennis MJ, Morgan AG, Burden RP, Blarney RW. Characteristics of cadaveric renal allograft recipients developing chronic rejection. Ann R Coll Surg Engl 1990; 72: 23.
15. Koskinenen P, Lemström K, Häyry P. Chronic rejection. Curr Opin Nephrol Hypertension 1996; 5: 269.
16. Almond PS, Matas AJ, Gillingham K, et al. Predictors of chronic rejection in renal transplant recipients. Transplant Proc 1993; 25: 936.
17. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early vs late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
18. Sumrani N, Cacciarelli TV, Georgi B, et al. Contribution of acute rejection to renal allograft loss from chronic rejection. Transplant Proc 1993; 25: 2259.
19. Kim SI, Kim MS, Kim YS, Jeong HJ, Park K. Biopsy-proven chronic rejection in living donor kidney transplantation: risk factors and graft survival. Transplant Proc 1997; 29: 100.
20. Moreso F, Serón D, Gil-Vernet S, et al. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999; 14: 930.
21. Matas AJ, Gillingham KJ, Payne WD, Najarian JS. The impact of an acute rejection episode on long-term renal allograft survival (t 1/2). Transplantation 1994; 57: 857.
22. Isoniemi H, Nurminen M, Tikkanen MJ, et al. Risk factors predicting chronic rejection of renal allografts. Transplantation 1994; 57: 68.
23. Barnas U, Schmidt A, Haas M et al. Parameters associated with chronic renal transplant failure. Nephrol Dial Transplant 1997; 12 (suppl 2): 82.
24. Dimény E, Fellström B, Larsson E, Tufveson G, Lithell H. Hyperlipoproteinemia in renal transplant recipients: is there a linkage with chronic vascular rejection? Transplant Proc 1993; 25: 2065.
25. Guijarro C, Massy ZA, Kasiske BL. Clinical correlation between renal allograft failure and hyperlipidemia. Kidney Int 1995; 48 (suppl): 52:S 56.
26. Simmons R L, Canafax DM, Strand M, et al. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. Transplant Proc 1985; 17: 4 suppl 1:266.
27. Reed E, Cohen DJ, Barr ML, et al. Effect of anti-HLA and anti-idiotypic antibodies on the long-time survival of heart and kidney allografts. Transplant Proc 1992; 24: 2494.
28. Campell MJ, Julious SA, Altman DG. Estimating sample size for binary, ordered categorical, and continuous outcome in two group comparisons. BMJ 1995; 3111: 1145. Correction in BMJ 1996;312:96.
29. Campell MJ, Julious SA, Altman DG. Estimating sample size for binary, ordered categorical, and continuous outcome in two group comparisons. BMJ 1995; 3111: 1145. Correction in BMJ 1996;312:96.
30. Knoll GA, Bell RC. Tacrolimus versus cyclosporine for immunosuppression in renal transplantation: meta-analysis of randomised trials. BMJ 1999; 318: 1104.